Showing results (271-280 of 378) with videos related to
Sort By:
Pageof 38
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 25, 2000
Ifosfamide plus oral etoposide salvage chemotherapy for platinum-resistant paclitaxel-pretreated ovarian cancerG Aravantinos, M A Dimopoulos, P Kosmidis, et al.Anticancer Research|August 10, 2002
Tumor volumetry as predictive and prognostic factor in the management of ovarian cancerE Andreopoulou, D Andreopoulos, K Adamidis, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 11, 2003
Phase II study of docetaxel-vinorelbine in platinum-resistant, paclitaxel-pretreated ovarian cancerG Aravantinos, D Bafaloukos, G Fountzilas, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 15, 2006
Automated quantitative analysis of DCC tumor suppressor protein in ovarian cancer tissue microarray shows association with beta-catenin levels and outcome in patients with epithelial ovarian cancerA Bamias, Z Yu, P M Weinberger, et al.European Journal of Gynaecological Oncology|May 8, 2007
Anthracycline-based adjuvant chemotherapy in early-stage uterine sarcomas: long-term results of a single institution experienceC A Papadimitriou, M P Zorzou, S Markaki, et al.Cancer|October 3, 2000
Paclitaxel, cisplatin, and epirubicin first-line chemotherapy in stage III and IV ovarian carcinoma: long-term results of a phase II studyC A Papadimitriou, L A Moulopoulos, G Vlahos, et al.European Journal of Haematology|February 13, 2001
Comparison of vincristine, carmustine, melphalan, cyclophosphamide, prednisone (VBMCP) and interferon-alpha with melphalan and prednisone (MP) and interferon-alpha (IFN-alpha) in patients with good-prognosis multiple myeloma: a prospective randomized study. Greek Myeloma Study GroupK Zervas, A Pouli, B Gregoraki, et al.Cancer Chemotherapy and Pharmacology|June 17, 2005
Phase I study of etoposide, cisplatin and irinotecan triplet in patients with advanced-stage small-cell lung cancerE Briasoulis, E Samantas, H Kalofonos, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 1999
Phase II trial of paclitaxel and cisplatin in metastatic and recurrent carcinoma of the uterine cervixC A Papadimitriou, K Sarris, L A Moulopoulos, et al.Seminars in Oncology|August 1, 1997
Second-line treatment of advanced non-small cell lung cancer with paclitaxel and gemcitabine: a preliminary report on an active regimenV Georgoulias, C Kourousis, S Kakolyris, et al.Pageof 38